Related Experiment Videos

Meningococcal carriage in close contacts of cases

K A Cartwright1, J M Stuart, P M Robinson

  • 1Gloucester Public Health Laboratory.

Insights

Meningococcal disease spread is linked to close contacts, especially household members. Rifampicin effectively eliminates meningococci carriage, and vaccination is recommended for specific cases to prevent further spread.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Microbiology

Background:

  • Meningococcal disease poses a public health risk, with understanding transmission dynamics crucial for control.
  • Nasopharyngeal carriage of Neisseria meningitidis is a key factor in disease spread.
  • Antibiotic resistance and treatment efficacy in carriage eradication require ongoing investigation.

Purpose of the Study:

  • To investigate meningococcal disease transmission patterns in close contacts.
  • To evaluate the efficacy of antibiotics, particularly rifampicin, in eradicating nasopharyngeal carriage.
  • To determine the role of household contacts in disease transmission and inform vaccination strategies.

Main Methods:

  • Retrospective analysis of 55 meningococcal disease cases and their close contacts (384 individuals).
  • Assessment of nasopharyngeal carriage rates of meningococci, including specific strains.
  • Evaluation of antibiotic treatment (including rifampicin) for carriage eradication.

Main Results:

  • A significant proportion of close contacts carried meningococci, with higher rates in household contacts.
  • A 2-day course of rifampicin eradicated carriage in 98% of colonized contacts.
  • In cases where meningococci were not isolated from deep sites, nasopharyngeal carriage in cases or household contacts indicated potential for further spread.

Conclusions:

  • Household contacts play a significant role in meningococcal disease transmission.
  • Rifampicin is a highly effective chemoprophylactic agent for eradicating meningococcal carriage.
  • Nasopharyngeal carriage data, combined with clinical presentation, can guide decisions on antibiotic prophylaxis and vaccination (e.g., meningococcal A + C vaccine).

Related Concept Videos